These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18615145)

  • 21. Ligand binding of PDZ domains has various roles in the synaptic clustering of SAP102 and PSD-95.
    Minatohara K; Ichikawa SH; Seki T; Fujiyoshi Y; Doi T
    Neurosci Lett; 2013 Jan; 533():44-9. PubMed ID: 23178474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal PDZ domains: a promising new molecular target for inhaled anesthetics?
    Tao YX; Johns RA
    Mol Interv; 2004 Aug; 4(4):215-21. PubMed ID: 15304557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD.
    Thorsen TS; Madsen KL; Rebola N; Rathje M; Anggono V; Bach A; Moreira IS; Stuhr-Hansen N; Dyhring T; Peters D; Beuming T; Huganir R; Weinstein H; Mulle C; Strømgaard K; Rønn LC; Gether U
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):413-8. PubMed ID: 20018661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice.
    Tao F; Su Q; Johns RA
    Mol Ther; 2008 Nov; 16(11):1776-82. PubMed ID: 18781143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors.
    Dong H; O'Brien RJ; Fung ET; Lanahan AA; Worley PF; Huganir RL
    Nature; 1997 Mar; 386(6622):279-84. PubMed ID: 9069286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stargazin and other transmembrane AMPA receptor regulating proteins interact with synaptic scaffolding protein MAGI-2 in brain.
    Deng F; Price MG; Davis CF; Mori M; Burgess DL
    J Neurosci; 2006 Jul; 26(30):7875-84. PubMed ID: 16870733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting PDZ domain proteins for treating NMDA receptor-mediated excitotoxicity.
    Wen W; Wang W; Zhang M
    Curr Top Med Chem; 2006; 6(7):711-21. PubMed ID: 16719811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate receptor anchoring proteins and the molecular organization of excitatory synapses.
    Sheng M; Pak DT
    Ann N Y Acad Sci; 1999 Apr; 868():483-93. PubMed ID: 10414325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain.
    Christopherson KS; Hillier BJ; Lim WA; Bredt DS
    J Biol Chem; 1999 Sep; 274(39):27467-73. PubMed ID: 10488080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand binding by PDZ domains.
    Chi CN; Bach A; Strømgaard K; Gianni S; Jemth P
    Biofactors; 2012; 38(5):338-48. PubMed ID: 22674855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging roles of Dlg-like PDZ proteins in the organization of the NMDA-type glutamatergic synapse.
    Nagano T; Jourdi H; Nawa H
    J Biochem; 1998 Nov; 124(5):869-75. PubMed ID: 9792906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity.
    Ehrlich I; Malinow R
    J Neurosci; 2004 Jan; 24(4):916-27. PubMed ID: 14749436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organization and dynamics of PDZ-domain-related supramodules in the postsynaptic density.
    Feng W; Zhang M
    Nat Rev Neurosci; 2009 Feb; 10(2):87-99. PubMed ID: 19153575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMDA Receptors at Primary Afferent-Excitatory Neuron Synapses Differentially Sustain Chemotherapy- and Nerve Trauma-Induced Chronic Pain.
    Huang Y; Chen H; Jin D; Chen SR; Pan HL
    J Neurosci; 2023 May; 43(21):3933-3948. PubMed ID: 37185237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP.
    Srivastava S; Osten P; Vilim FS; Khatri L; Inman G; States B; Daly C; DeSouza S; Abagyan R; Valtschanoff JG; Weinberg RJ; Ziff EB
    Neuron; 1998 Sep; 21(3):581-91. PubMed ID: 9768844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryptic protein-protein interaction motifs in the cytoplasmic domain of MHCI proteins.
    Frietze KK; Pappy AL; Melson JW; O'Driscoll EE; Tyler CM; Perlman DH; Boulanger LM
    BMC Immunol; 2016 Jul; 17(1):24. PubMed ID: 27435737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo composition of NMDA receptor signaling complexes differs between membrane subdomains and is modulated by PSD-95 and PSD-93.
    Delint-Ramirez I; Fernández E; Bayés A; Kicsi E; Komiyama NH; Grant SG
    J Neurosci; 2010 Jun; 30(24):8162-70. PubMed ID: 20554866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of transmembrane AMPA receptor regulatory proteins with multiple membrane associated guanylate kinases.
    Dakoji S; Tomita S; Karimzadegan S; Nicoll RA; Bredt DS
    Neuropharmacology; 2003 Nov; 45(6):849-56. PubMed ID: 14529722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slitrk2 controls excitatory synapse development via PDZ-mediated protein interactions.
    Han KA; Kim J; Kim H; Kim D; Lim D; Ko J; Um JW
    Sci Rep; 2019 Nov; 9(1):17094. PubMed ID: 31745231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain.
    D'Mello R; Marchand F; Pezet S; McMahon SB; Dickenson AH
    Mol Ther; 2011 Oct; 19(10):1780-92. PubMed ID: 21427709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.